COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica: Mise à disposition du Rapport financier semestriel 2026
29/07/2026
Mise à disposition du Rapport financier semestriel 2026 Paris, France (29 juillet 2026 – 18h00) – Le Conseil d’administration d’EssilorLuxottica, qui s’est réuni le 28 juillet 2026, a arrêté les comptes consolidés [...]
First-half 2026 results
29/07/2026
Half-Year Results: strong improvement in operating performance Successful refinancing transactions Objectives confirmed Strong improvement in operating performance Revenue as at 30 June 2026 stood at €2,699m, up +4.6% [...]
Résultats semestriels 2026
29/07/2026
Résultats au 30 juin 2026 : forte progression de la performance opérationnelle Succès des opérations de refinancement Objectifs confirmés Forte progression de la performance opérationnelle Le chiffre d’affaires au 30 [...]
First-Half 2026 results confirm commercial and operational resilience in a challenging market environment - Transformation progressing as planned, including the divestment of the Brindisi site
29/07/2026
Press Release Paris, 29th July 2026 €356.5 million Net Sales, down 13.5% year-on-year as reported and -11.8% on a comparative basis 1 As expected, including a negative €13 million impact from the planned discontinuation [...]
Les résultats du premier semestre 2026 confirment la résilience commerciale et opérationnelle dans un environnement de marché difficile - La transformation progresse selon le calendrier avec notamment la cession du site de Brindisi
29/07/2026
Communiqué de presse Paris, le 29 juillet 2026 Chiffre d’affaires de 356,5 millions d’euros, en baisse de 13,5% par rapport au S1 2025 et de -11,8% sur une base comparable 1 Comme prévu, incluant un impact négatif de 13 [...]
F6S Ranks Life Backup Plan 55th in Health and Wellness
29/07/2026
National ranking accompanies recognition from Pepperdine, TiE, ASCEND LA and two healthcare publications Aliso Viejo, CA, July 29, 2026 (GLOBE NEWSWIRE) -- F6S ranks Life Backup Plan® 55th on its, “ 100 Top Health [...]
New Research using Clue Data Suggests Menstrual Cycle Timing May Influence Vaccine Side Effects
29/07/2026
A new study using Clue's menstrual tracking data finds women vaccinated during the follicular phase were more likely to self-report side effects and had a longer time to subsequent infection than those vaccinated during [...]
Cynet Releases 1H 2026 CyOps ECHO Report: Abused Identities, Gateways, and Trust Take the Place of Exploited Code
29/07/2026
Incident responders document how adversaries are gaining initial footholds through stolen or socially-engineered identities rather than CVE exploitation BOSTON, July 29, 2026 (GLOBE NEWSWIRE) -- Cynet , the only unified [...]
Rose Hill Life Sciences Appoints Bryan Smith as Scientific Advisor
29/07/2026
Veteran Drug Discovery Executive Brings Nearly Two Decades of Oncology and Translational Research Leadership to Advance Rose Hill’s Clinical Pipeline BOSTON, July 29, 2026 (GLOBE NEWSWIRE) -- Rose Hill Life Sciences (“ [...]
Angelman Syndrome Foundation and Citizen Health Partner to Put Advanced AI to Work for Every Angelman Family
29/07/2026
Citizen Health's AI advocate for rare disease families debuts for the Angelman community at the 2026 ASF Family Conference SAN FRANCISCO and DENVER, July 29, 2026 (GLOBE NEWSWIRE) -- The Angelman Syndrome Foundation ( [...]
SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company
29/07/2026
TEL AVIV, Israel, July 29, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company [...]
Clene to Present at The Canaccord 46th Annual Growth Conference
29/07/2026
SALT LAKE CITY, July 29, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company [...]
NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative
29/07/2026
Deployment follows a successful peak-shaving pilot that projected over $100,000 in seasonal demand cost savings Boca Raton, Fla., July 29, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions, Inc. ("NOMAD" or the "Company [...]
RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET
29/07/2026
MOUNTAIN VIEW, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT) , a life sciences company developing innovative targeted oncology therapies and commercializing [...]
CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026
29/07/2026
PARSIPPANY, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that it will report its financial results for the second quarter ended June 30, 2026, before the market opens on [...]
PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀
29/07/2026
PDUFA target action date of November 28, 2026, approximately one quarter ahead of Company’s previously communicated guidance FDA identified no Filing review issues Acceptance triggers $15 million milestone payment, [...]
TOMI Environmental Solutions Reaffirms $12 Million Revenue Guidance for Fiscal 2026 and Confirms $35 Million Sales Pipeline with $8.6 Million in Advanced Stages
29/07/2026
-Carbonium Merger Remains on Track -European Regulatory Expansion and Partnership Growth -Advancement of Biosafety Cabinet Standards -Defense Sector Growth FREDERICK, Md., July 29, 2026 (GLOBE NEWSWIRE) -- TOMI [...]
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
29/07/2026
WEST PALM BEACH, FL, July 29, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc.’s (OTC: FOXOD/FOXO) ( “FOXO”) subsidiary, Vector BioSource, Inc. (“Vector”) today announced that it has entered into a definitive agreement [...]
Biodexa Initiates Support Activities for FAP Patients and Treatment Centers in France
29/07/2026
July 28, 2026 Biodexa Initiates Support Activities for FAP Patients and Treatment Centers in France Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing innovative products [...]

Pages